Cathay Financial Statements From 2010 to 2024

Stocks . China . 
Stock . Cathay Biotech
688065 Stock   42.84  0.22  0.51%   
Cathay Biotech financial statements provide useful quarterly and yearly information to potential Cathay Biotech investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cathay Biotech financial statements helps investors assess Cathay Biotech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cathay Biotech's valuation are summarized below:
Gross Profit
2.4 B
Profit Margin
0.1439
Market Capitalization
25 B
Enterprise Value Revenue
7.8808
Revenue
2.8 B
We have found fifty-three available fundamental signals for Cathay Biotech, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Cathay Biotech prevailing market performance against the performance between 2010 and 2024 to make sure the company can sustain itself down the road.

Cathay Biotech Total Revenue

2.27 Billion

Check Cathay Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cathay Biotech's main balance sheet or income statement drivers, such as Tax Provision of 56.8 M, Net Interest Income of 134.7 M or Interest Income of 156.9 M, as well as many indicators such as . Cathay financial statements analysis is a perfect complement when working with Cathay Biotech Valuation or Volatility modules.
  
This module can also supplement various Cathay Biotech Technical models . Check out the analysis of Cathay Biotech Correlation against competitors.

Cathay Biotech Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets15.6 B18.8 B9.4 B
Slightly volatile
Other Current Liabilities4.3 M5.9 M11.1 M
Slightly volatile
Total Current Liabilities3.6 B3.4 B1.4 B
Slightly volatile
Total Stockholder Equity10.5 B11.2 B6.7 B
Slightly volatile
Retained Earnings1.6 B2.1 B1.1 B
Slightly volatile
Accounts Payable911.8 M1.7 B785.2 M
Pretty Stable
Cash6 B5.4 B2.4 B
Slightly volatile
Non Current Assets Total7.1 B11.3 B4.6 B
Slightly volatile
Non Currrent Assets Other918.8 M876.5 M357.6 M
Slightly volatile
Long Term Debt471.5 M245.3 M293.2 M
Slightly volatile
Net Receivables271.7 M243.3 M192.7 M
Slightly volatile
Common Stock Shares Outstanding628.8 M583.4 M547.5 M
Slightly volatile
Short Term Investments401.2 K422.3 K661.6 M
Slightly volatile
Non Current Liabilities Total621.3 M650.5 M409.6 M
Slightly volatile
Inventory1.3 B1.5 B972.3 M
Slightly volatile
Other Current Assets193.1 M287.2 M279.3 M
Slightly volatile
Total Liabilities2.3 B4.1 B1.6 B
Slightly volatile
Net Invested Capital11.4 B12.9 B7.2 B
Slightly volatile
Short and Long Term Debt1.6 B1.5 B466.3 M
Slightly volatile
Total Current Assets8.5 B7.6 B4.8 B
Slightly volatile
Capital Stock522.5 M583.4 M418.2 M
Slightly volatile
Net Working Capital6.8 B4.2 B3.5 B
Slightly volatile
Intangible Assets596.1 M703.9 M359 M
Slightly volatile
Property Plant And Equipment Net6 B9.4 B3.7 B
Slightly volatile
Property Plant And Equipment Gross6.8 B10.5 B4.2 B
Slightly volatile

Cathay Biotech Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision56.8 M40.4 M73.7 M
Slightly volatile
Interest Income156.9 M219.8 M64.1 M
Slightly volatile
Interest Expense19.7 M32.2 M17.5 M
Pretty Stable
Selling General Administrative83.2 M103 M124.8 M
Slightly volatile
Total Revenue2.3 B2.1 B2 B
Slightly volatile
Gross Profit618.3 M608.8 M811.9 M
Slightly volatile
Operating Income371.7 M273.3 M519.4 M
Slightly volatile
Net Income From Continuing Ops570 M408.5 M498.1 M
Slightly volatile
Research Development150.7 M189.1 M109.8 M
Slightly volatile
EBITDA827.5 M1.1 B751.7 M
Slightly volatile
Cost Of Revenue1.4 B1.5 B1.2 B
Slightly volatile
Total Operating Expenses1.8 B1.8 B1.5 B
Slightly volatile
Reconciled Depreciation209.9 M285.7 M147.4 M
Slightly volatile
Income Before Tax471.4 M448.9 M561.3 M
Very volatile
Net Income392.2 M366.5 M476.9 M
Pretty Stable

Cathay Biotech Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow4.7 B6.2 B1.8 B
Slightly volatile
Depreciation209.9 M285.7 M147.4 M
Slightly volatile
Dividends Paid178.1 M137.7 M138.6 M
Slightly volatile
Capital Expenditures1.9 B1.6 B999.4 M
Slightly volatile
Total Cash From Operating Activities625.2 M569.5 M446.9 M
Slightly volatile
Net Income394.3 M366.5 M477.9 M
Pretty Stable
End Period Cash Flow5.8 B5 B2.3 B
Slightly volatile

About Cathay Biotech Financial Statements

Cathay Biotech stakeholders use historical fundamental indicators, such as Cathay Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cathay Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cathay Biotech's assets and liabilities are reflected in the revenues and expenses on Cathay Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cathay Biotech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue2.1 B2.3 B
Cost Of Revenue1.5 B1.4 B

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Cathay Stock

Cathay Biotech financial ratios help investors to determine whether Cathay Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cathay with respect to the benefits of owning Cathay Biotech security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY